|Primary analysis complete
|Study Start Date:
|Study Made Public:
A Phase 1b clinical trial to evaluate the safety and immunogenicity of heterologous prime/boost vaccine regimens (NYVAC-B/rAd5 vs. rAd5/NYVAC-B) in healthy, HIV-1 uninfected, Ad5 seronegative adult participants
HVTN 078 is a Phase Ib clinical trial to evaluate the safety and immunogenicity of prime/boost regimens using combinations of NYVAC-B/rAd5 and rAd5/NYVAC-B.
Sign in to see full information about this study and to download study data.
ProductsProduct info coming soon!
No integrated data is available for this study.
No non-integrated data is available for this study.